Novo’s Wegovy pill planned to enter US self-checkout channels, Reuters says
Novo Nordisk (NVO) the newly approved version of Wegovy is scheduled to arrive directly to US self-checkout channels in early January, Reuters’ Maggie Fick reports. As part of the company’s agreement with the Trump administration in November, Novo and Lilly (LYLY) agreed to sell initial doses of their weight-loss pills for $149 a month to…